关键词：磷；生理功能；神经功能；肌肉收缩；钙的磷酸盐；结合剂；治疗
摘 要：Phosphorus is an important element for normal physiologic functions such as bone construction, nerve function, and muscle contraction. About 85% of phosphorus is stored in the bones and different tissues in the body. The excess phosphorus is eliminated from the body by the urinary system. The normal phosphate level in the blood is 3-4 mg/dL. Electrolytic disturbance resulting in high levels of phosphate in the blood causes hyperphosphatemia in individuals. Individuals with chronic kidney diseases (CKDs) have a decreased glomerular filtration rate (GFR) and increased serum phosphate levels.
目 录：

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Product profiles

PART 05: Introduction

Key market highlights

PART 06: Disease Overview

Understanding the disease

Etiology

Effects of hyperphosphatemia

Causes

Signs and symptoms

Diagnosis

Management

Epidemiology

PART 07: Key developments in hyperphosphatemia

therapy

PART 08: Guidelines for use of phosphate binders

CKD stages 2-4

CKD stage 5

PART 09: Pipeline analysis

Information on pipeline candidates

PART 10: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 11: Hyperphosphatemia management market

dynamics

PART 12: Market segmentation by dosage form

Solid

Liquid

PART 13: Market segmentation by formulation

Aluminum-based phosphate binders

Calcium-based phosphate binders

Aluminum-free, calcium-free phosphate binder

Magnesium-based phosphate binders

Iron-based phosphate binders

PART 14: Geographical segmentation

Global hyperphosphatemia drugs market segmentation

by geography

Hyperphosphatemia drugs market in Americas

Hyperphosphatemia drugs market in EMEA

Hyperphosphatemia drugs market in APAC

PART 15: Key leading countries

Key leading countries

Hyperphosphatemia drugs market in the US

Hyperphosphatemia drugs market in Japan

PART 16: Market drivers

PART 17: Impact of drivers

PART 18: Market challenges

PART 19: Impact of drivers and challenges

PART 20: Market trends

PART 21: Vendor landscape

Competitive scenario

Market share analysis 2014

Brand differentiation

Other prominent vendors

PART 22: Key vendor analysis

Fresenius Medical Care

Keryx Biopharmaceuticals

Sanofi

Shire

Vifor Pharma

PART 23: Appendix

List of abbreviation

PART 24: Explore Technavio